I was diagnosed with COPD last year after struggling with multiple symptoms. I quit smoking over 10 years ago, but I'm dealing with the effects of it ...

In recent weeks there has been a buzz around a new treatment breakthrough: benralizumab, which in a study published in the ...

As winter sets in there has been a noticeable rise in Pakistani citizens respiratory illnesses over the past few weeks ...

The list includes a number of common respiratory health conditions such as asthma, pneumonia, sleep apnoea and chronic ...

The holiday season is a time for joy, family and exciting celebrations. However, for those individuals living with chronic illnesses, managing their health during this time can be an added ...

The phase 1 clinical trial of APG333 is designed as a double-blind, placebo-controlled, first-in-human, single-ascending dose trial in healthy volunteers. It is expected to enroll approximately 32 ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulm ...

Apogee Therapeutics (APGE) announced that it has initiated dosing of healthy volunteers in its clinical trial of APG333, a novel, subcutaneous ...

By Dr Shivraj A.L. Chronic Obstructive Pulmonary Disease (COPD) is a lung condition that is progressive and debilitating in ...

Mepolizumab, a biologic approved for asthma, is not currently approved for COPD, but data from a 2017 study showed a trend ...

Massachusetts families are still struggling to find alternatives almost a year after GlaxoSmithKline canceled a widely ...